Confluence Genetics

Confluence Genetics is a seed innovation company that combines world-leading proprietary germplasm with AI-driven plant breeding technology to unlock nature's genetic diversity in soy quality traits. The company's proprietary CropOS® platform harnesses artificial intelligence and machine learning to accelerate predictive breeding, supported by a Crop Accelerator speed-breeding facility capable of running more than four crop cycles per year. Confluence Genetics serves the feed, food, and fuel markets with differentiated soybean varieties — including its flagship Ultra-High Protein, Low Oligosaccharide (UHP-LO) soybean — and expanded its portfolio in 2025 by acquiring soybean assets from Benson Hill. The company is backed by S2G Investments and operates with a nature-positive, technology-driven approach to closing the global protein gap.